Please Wait

Applying Filters...

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Dihydroergotamine

Dihydroergotamine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 7 USDMF, 3 CEP/COS, 9 NDC API, 4 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

31 Drugs in Development

31 Drugs in Development

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 16 FDA Orange Book, 4 Europe, 2 Canada, 2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 Actylis, 1 Kerry, 1 Pluviaendo

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 1 Coating Systems & Additives, 1 Topical, 1 Controlled & Modified Release, 1 Film Formers & Plasticizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices, 4 Annual Reports

MARKET PLACE

4 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 US Exclusivities, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 JP, 1 Others

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

1 All

01 1IMPEL PHARMS

filter Product Reset all filters

filter Exclusivity Expiration Date Reset all filters

filter Exclusivity Code Reset all filters

Product Main Page

01

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

Luxepack

Not Confirmed

Contact us
to update this info